Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agomelatine for generalized anxiety disorder in non-depressed outpatients
2009-013789-17Phase 3Completed
- Sponsor
- Servier
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in generalized anxiety disorder (GAD) comparing Agomelatine with Placebo (2 arms). Primary endpoint: Hamilton Anxiety Rating Scale total score. Started Jan 2010; status: completed.
02
Drugs
agomelatine
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on 2009-013789-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013789-17.